Pre-workout Supplement Versus Caffeine on Energy Expenditure.

August 31, 2020 updated by: Clayton Camic, Northern Illinois University

Effects of a Multi-ingredient Pre-workout Supplement Versus Caffeine on Energy Expenditure and Feelings of Fatigue During Low-intensity Treadmill Exercise in College-aged Males.

The primary purpose of this study was to examine the acute effects of a multi-ingredient pre-workout supplement versus an ergogenic dose of caffeine (6 mg/kg) on energy expenditure during low-intensity exercise. The effects of these substances on substrate utilization, gas exchange, and psychological factors were also investigated. Twelve males (mean ± SD: age = 22.8 ± 2.4 years) completed three bouts of 60-min of treadmill exercise at 4.8-6.4 km/hr on separate days after consuming a pre-workout supplement, 6 mg/kg of caffeine, or placebo in a randomized fashion. The pre-workout and caffeine supplements resulted in significantly greater energy expenditure (p < 0.001, p = 0.006, respectively), VO2 (p < 0.001, p = 0.007, respectively), VCO2 (p = 0.006, p = 0.049, respectively), and VE (p < 0.001, p = 0.007, respectively), but not rates of fat or carbohydrate oxidation or respiratory exchange ratio compared to placebo (collapsed across condition). In addition, the pre-workout supplement increased feelings of alertness (p = 0.015) and focus (p = 0.005) 30-minutes post-ingestion and decreased feelings of fatigue (p = 0.014) during exercise compared to placebo (collapsed across condition). Thus, the pre-workout supplement increased energy expenditure and measures of gas exchange to the same extent as 6 mg/kg of caffeine with concomitant increased feelings of alertness and focus and decreased feelings of fatigue.

Study Overview

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • DeKalb, Illinois, United States, 60115
        • Exercise Physiology Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 29 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male

Exclusion Criteria:

  • history of medical or surgical events, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders;
  • use of any medications
  • use of nutritional supplements
  • habitual use of caffeine (≥1 caffeinated beverage per day)
  • participation in another clinical trial or investigation of another investigational product within 30 days prior to screening/enrollment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pre-Workout Condition
This condition consisted of the ingestion of one serving of the pre-workout supplement.
ENGN Shred is a multi-ingredient pre-workout supplement.
Experimental: Caffeine Condition
This condition consisted of the ingestion of 6 mg of caffeine per kg of body mass.
Caffeine powder.
Placebo Comparator: Placebo condition
This condition consisted of the ingestion of a placebo.
Non-caloric Crystal Light matched for the pre-workout in terms of flavor and consistency.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Energy expenditure
Time Frame: Measured continuously during 60 minutes of exercise for all three supplement conditions
Measurement of caloric expenditure via gas exchange
Measured continuously during 60 minutes of exercise for all three supplement conditions

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen consumption
Time Frame: Measured continuously during 60 minutes of exercise for all three supplement conditions
Measurement of rate of oxygen consumption using a metabolic cart
Measured continuously during 60 minutes of exercise for all three supplement conditions
Carbon dioxide production
Time Frame: Measured continuously during 60 minutes of exercise for all three supplement conditions
Measurement of rate of carbon dioxide production using a metabolic cart
Measured continuously during 60 minutes of exercise for all three supplement conditions
Minute ventilation
Time Frame: Measured continuously during 60 minutes of exercise for all three supplement conditions
Measurement of ventilation rate using a metabolic cart
Measured continuously during 60 minutes of exercise for all three supplement conditions
Feelings of fatigue
Time Frame: Baseline, 30-minutes post-ingestion of supplement, and at the 30-minute time point of exercise for all three supplement conditions
Subjects were asked to rate their feelings of fatigue using a 5-point Likert scale
Baseline, 30-minutes post-ingestion of supplement, and at the 30-minute time point of exercise for all three supplement conditions
Feelings of energy
Time Frame: Baseline, 30-minutes post-ingestion of supplement, and at the 30-minute time point of exercise for all three supplement conditions
Subjects were asked to rate their feelings of energy using a 5-point Likert scale
Baseline, 30-minutes post-ingestion of supplement, and at the 30-minute time point of exercise for all three supplement conditions
Feelings of focus
Time Frame: Baseline, 30-minutes post-ingestion of supplement, and at the 30-minute time point of exercise for all three supplement conditions
Subjects were asked to rate their feelings of focus using a 5-point Likert scale
Baseline, 30-minutes post-ingestion of supplement, and at the 30-minute time point of exercise for all three supplement conditions
Feelings of alertness
Time Frame: Baseline, 30-minutes post-ingestion of supplement, and at the 30-minute time point of exercise for all three supplement conditions
Subjects were asked to rate their feelings of focus using a 5-point Likert scale
Baseline, 30-minutes post-ingestion of supplement, and at the 30-minute time point of exercise for all three supplement conditions
Rate of fat oxidation
Time Frame: Measured continuously during 60 minutes of exercise for all three supplement conditions
Fat oxidation was estimated thru measurements of gas exchange
Measured continuously during 60 minutes of exercise for all three supplement conditions
Rate of carbohydrate oxidation
Time Frame: Measured continuously during 60 minutes of exercise for all three supplement conditions
Carbohydrate oxidation was estimated thru measurements of gas exchange
Measured continuously during 60 minutes of exercise for all three supplement conditions

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Clayton L Camic, PhD, Northern Illinois University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2019

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

August 26, 2020

First Submitted That Met QC Criteria

August 31, 2020

First Posted (Actual)

September 4, 2020

Study Record Updates

Last Update Posted (Actual)

September 4, 2020

Last Update Submitted That Met QC Criteria

August 31, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on ENGN Shred

3
Subscribe